At IQVIA Laboratories Biosciences, we lead the way in oligonucleotide drug development, offering advanced bioanalytical services for siRNA, antisense oligonucleotides (ASOs), aptamers, and antibody-oligonucleotide conjugates (AOCs). Our science-driven approach combines LC-MS/MS, high-resolution mass spectrometry (HRMS), and ligand binding immunoassays to deliver sensitive, specific, and regulatory-compliant data across preclinical and clinical studies. With deep expertise in ADME analysis, oligonucleotide pharmacokinetics, and bioanalytical method validation, we help accelerate your therapeutic pipeline with confidence.
Looking for expert LC-MS bioanalysis and immunoassay support for siRNA or oligonucleotide therapeutics? Download this helpful fact sheet now!
Download Document
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Assays and Why Are They Essential for Protein Bioanalysis?
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Assay Development for Large-Scale Clinical Studies
Bioanalytical expertise to support large-scale, international studies
